Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
J.M. Smucker
SJM
$13.3B
| $294K | ﹤0.01% |
3,005
+398
| +15% | +$41.1K |
|
1577
Manitowoc
MTW
$693M
| $294K | ﹤0.01% |
+24,480
| New | +$278K |
|
1578
Virtus Investment Partners
VRTS
$1.11B
| $293K | ﹤0.01% |
1,796
-10,764
| -86% | -$1.82M |
|
1579
NB Bancorp
NBBK
$980M
| $290K | ﹤0.01% |
+14,651
| New | +$279K |
|
1580
First Citizens BancShares
FCNCA
$24.4B
| $290K | ﹤0.01% |
135
-993
| -88% | -$1.87M |
|
1581
Essential Utilities
WTRG
$11.5B
| $289K | ﹤0.01% |
+7,544
| New | +$297K |
|
1582
Asbury Automotive
ABG
$3.8B
| $287K | ﹤0.01% |
+1,236
| New | +$292K |
|
1583
3M
MMM
$92.7B
| $287K | ﹤0.01% |
1,792
-174,291
| -99% | -$28.5M |
|
1584
Hamilton Lane
HLNE
$4.58B
| $287K | ﹤0.01% |
2,134
-3,167
| -60% | -$398K |
|
1585
iShares MSCI Mexico ETF
EWW
$1.8B
| $286K | ﹤0.01% |
4,128
| – | – |
|
1586
Park National Corp
PRK
$3.63B
| $286K | ﹤0.01% |
+1,877
| New | +$295K |
|
1587
Hershey
HSY
$37.4B
| $284K | ﹤0.01% |
+1,562
| New | +$286K |
|
1588
Owlet
OWLT
$153M
| $283K | ﹤0.01% |
+17,510
| New | +$198K |
|
1589
Emergent Biosolutions
EBS
$277M
| $283K | ﹤0.01% |
+22,910
| New | +$245K |
|
1590
MillerKnoll
MLKN
$1.57B
| $282K | ﹤0.01% |
+15,434
| New | +$252K |
|
1591
Revvity
RVTY
$13.9B
| $281K | ﹤0.01% |
2,904
-72,153
| -96% | -$6.93M |
|
1592
Evolv Technologies
EVLV
$969M
| $280K | ﹤0.01% |
+39,081
| New | +$278K |
|
1593
Flotek Industries
FTK
$871M
| $280K | ﹤0.01% |
+16,229
| New | +$258K |
|
|
ESPR
1594
DELISTED
Esperion Therapeutics
ESPR
| $278K | ﹤0.01% |
+75,238
| New | +$243K |
|
1595
United States Antimony
UAMY
$780M
| $278K | ﹤0.01% |
55,352
+250
| +0.5% | +$1.96K |
|
|
RTACU
1596
Renatus Tactical Acquisition Corp I Unit
RTACU
$188M
| $277K | ﹤0.01% |
25,000
| – | – |
|
1597
Triumph Financial Inc
TFIN
$1.76B
| $277K | ﹤0.01% |
+4,417
| New | +$247K |
|
1598
Citi Trends
CTRN
$564M
| $276K | ﹤0.01% |
+6,653
| New | +$263K |
|
1599
Pagaya Technologies
PGY
$1.79B
| $276K | ﹤0.01% |
13,201
-15,100
| -53% | -$385K |
|
1600
Syndax Pharmaceuticals
SNDX
$1.79B
| $275K | ﹤0.01% |
13,100
-119,023
| -90% | -$2.08M |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.